Science Explorer Back to mapMap
Discussion
Researcher · Virginia Oncology Associates · United States

Paul Conkling

Paul Conkling publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

ORCID 0009-0002-9501-4482 OpenAlex
World rank
#1,731,979
of 7,710,434 ranked researchers
Rank in United States
#534,550
of 1,627,098
Works
140
Citations
4.1k
Citations per work
29.3
h-index
27
i10-index 50Top 14% in Oncology
Paul Conkling

What does Paul Conkling research?

Paul Conkling's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (13%).

Health Sciences: 83 works · 59.2% of their workMedicine: 83 works · 59.2% of their workOncology: 42 works · 30.1% of their workPulmonary and Respiratory Medicine: 25 works · 18.1% of their workHematology: 9 works · 6.4% of their workEpidemiology: 6 works · 4.6% of their workEverything else: 39 works · 27.8% of their workLife Sciences: 18 works · 13.0% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 13.0% of their workMolecular Biology: 12 works · 8.7% of their workCancer Research: 6 works · 4.3% of their workTHEIR WORKPaul Conkling140works
Life Sciences13%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8359.2%
  2. Everything else3927.8%
    1. Biochemistry, Genetics and Molecular Biology1813.0%
  1. 1Oncology30% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Molecular Biology9% of their works
  4. 4Hematology6% of their works
  5. 5Epidemiology5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Paul Conkling's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Prognostic Factors, Breast Cancer, Immune Checkpoint Blockade, Metastatic Breast Cancer and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Clinical Trials542 topics
  2. Targeted Therapy542 topics
  3. Chemotherapy412 topics
  4. Prognostic Factors362 topics
  5. Breast Cancer322 topics
  6. Immune Checkpoint Blockade301 topic
  7. Metastatic Breast Cancer302 topics
  8. PD-1 and PD-L1301 topic
  9. ALK Inhibitors291 topic
  10. EGFR Mutations291 topic
  11. Genomic Profiles251 topic
  12. Small-Cell Lung Cancer251 topic
  13. CDK4/6 Inhibitors161 topic
  14. HER2161 topic
  15. Palbociclib161 topic
  16. Trastuzumab161 topic
  17. Chemotherapy-Induced Peripheral Neuropathy141 topic
  18. Taxanes141 topic
  19. Breast Tumours111 topic
  20. Chronic Lymphocytic Leukemia111 topic
  21. Gene Expression111 topic
  22. Genomic Aberrations111 topic

Where does Paul Conkling work?

Paul Conkling's main affiliation in the publication record is Virginia Oncology Associates, United States.

How many publications and citations does Paul Conkling have?

OpenAlex counts 140 works and 4,107 citations for Paul Conkling, an h-index of 27, ranking #1,731,979 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paul Conkling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.